Key Highlights: Implications: Mankind Pharma’s €48 million investment for a 70% stake in ACTx signals a strategic shift toward high-value oncology and next-generation CAR-T therapies. ACTx...
Browsing Tag: chimeric antigen receptor T-cell therapy
1
2
3
